Haemonetics ( HAE) was initiated with a market outperform rating at JMP Securities. The company's leading market position will be bolstered by M&A, and significant margin expansion is expected ahead, JMP said. Price target is $52. Lifepoint ( LPNT) was upgraded at Credit Suisse to outperform from neutral. Nonurban hospitals are best positioned for health care reform, Credit Suisse said. LRR Energy ( LRE) was downgraded to sell at TheStreet Ratings. Oracle ( ORCL) was downgraded at Berenberg to sell. $28 price target. Company may lag the pace of innovation in the software sector, Berenberg said.
Realpage ( RP) was downgraded to sell at TheStreet Ratings. Tenet Healthcare ( THC) was upgraded at Deutsche Bank to buy. $55 price target. Stock is attractive, following the recent pullback, Deutsche Bank said. VMWare ( VMW) was downgraded at Berenberg to sell. $57 price target. Company may be left behind by new technology trends, Berenberg said. WR Berkley ( WRB) was upgraded at Bank of America/Merrill Lynch to buy from neutral. $46 price target. Stock is attractive, following a 12% pullback, BofA/Merrill said.
Stock Comments / EPS ChangesBrown-Forman ( BF.B) estimates were reduced at UBS. Lower volume and pricing increased, said UBS.
VeriFone ( PAY) price target and estimates were reduced at UBS. Legacy issues are taking longer to resolve than expected, said UBS. Price target goes to $21. Swift ( SWFT) estimates, target were raised at Keybanc. Shares are now seen reaching $20. Estimates were also increased, given higher seasonal demand and more favorable diesel costs, Keybanc said. Buy rating. >To submit a news tip, email: email@example.com. Follow TheStreet on Twitter and become a fan on Facebook.